Alyssa George on Clinical and Economic Impact of a Eptacog Beta
Alyssa George, Clinical Pharmacist at Henry Ford Health, shared on LinkedIn:
”I am excited to share that my medication use evaluation looking at the use of recombinant factor VIIa has been published in Clinical and Applied Thrombosis and Hemostasis!
For the last two years, we have been working on putting together this manuscript to report our clinical experiences and economical savings with a recombinant factor VIIa formulary interchange from eptacog alfa to eptacog beta.
We successfully used eptacog beta for several labeled and off-label indications, including bleeding and peri-operative management for those with acquired or congenital hemophilia A/B, delta granule storage pool disorder, and intra-operative coagulopathy during cardiac surgery.
We found no incidence of thrombotic events and a low rate of bleeding complications.
For those interested, the article is linked below.
I would like to thank my preceptors Katelyn Sylvester and Dareen Kanaan for all of their hard work on helping me get this manuscript published!”
Read the full article here.
Article: Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center
Authors: Alyssa George, Katelyn Sylvester, Dareen Kanaan, Prabashni Reddy, John Fanikos, Jean Connors, Nathan Connell
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency